(Q46584324)

23 December 2017

title

Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality (English)

1 reference

23 December 2017

1 reference

Demers RY

1

1 reference

23 December 2017

Tiwari A

2

1 reference

23 December 2017

Wei J

3

1 reference

23 December 2017

Weiss LK

4

1 reference

23 December 2017

Severson RK

5

1 reference

23 December 2017

Montie J

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

23 December 2017

published in

Cancer

1 reference

23 December 2017

volume

92

1 reference

23 December 2017

page(s)

2309-2317

1 reference

23 December 2017

issue

9

1 reference

23 December 2017

The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

The Papanicolaou test for cervical cancer detection. A triumph and a tragedy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Why is the prostate cancer death rate declining in the United States?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Proceedings: franzen aspiration biopsy of prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

American Cancer Society guidelines for the early detection of prostate cancer: update, June 10, 1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

The role of bone scanning in the assessment of prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Prostate biopsy utilizing transrectal ultrasound guidance: diagnosis of nonpalpable cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Ultrasound-guided prostate biopsy. Biopty gun superior to aspiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

The role of neoadjuvant hormonal manipulation in localized prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Clinical efficacy and safety of a new leuprorelin acetate depot formulation in patients with advanced prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

External beam radiation therapy of primary carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011101%2992%3A9%3C2309%3A%3AAID-CNCR1577%3E3.0.CO%3B2-8

10.1002/1097-0142(20011101)92:9<2309::AID-CNCR1577>3.0.CO;2-8

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

11745285

1 reference

23 December 2017